Tonix Pharmaceuticals Holding Corp. (TNXP)

NASDAQ: TNXP · Real-Time Price · USD

12.71

-0.13 (-1.01%)

At close: Apr 28, 2026, 4:00 PM EDT

12.89

+0.18 (1.42%)

After-hours: Apr 28, 2026, 7:38 PM EDT

TNXP Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for TNXP.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for TNXP.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	2	2	2	2	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert LeBoyer Noble Capital Markets	Noble Capital Markets	Buy Reiterates $70	Buy	Reiterates	$70	+450.75%	Mar 20, 2025
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $600 → $1,100	Strong Buy	Maintains	$600 → $1,100	+8,554.60%	Jul 22, 2024
Jason Kolbert Dawson James	Dawson James	Strong Buy Initiates $9,600	Strong Buy	Initiates	$9,600	+75,431.08%	Feb 28, 2024
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $57,600 → $25,600	Strong Buy	Maintains	$57,600 → $25,600	+201,316.21%	Aug 1, 2023
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $20,800 → $57,600	Strong Buy	Maintains	$20,800 → $57,600	+453,086.47%	Jun 2, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

86.26M

from 13.11M

558.11%

from 13.11M

Revenue Next Year

119.29M

from 86.26M

38.29%

from 86.26M

EPS This Year

-9.45

from -14.57

EPS Next Year

-3.77

from -9.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	7.77M	10.09M	13.11M	86.26M	119.29M
Revenue Growth	-	-	-	29.94%	29.85%	558.11%	38.29%
EPS	-	-	-	-176.60	-14.57	-9.45	-3.77
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	213.7M	139.1M
Avg	86.3M	119.3M
Low	21.6M	99.4M

Revenue Growth

Revenue Growth	2026	2027
High	1,530.3%	61.3%
Avg	558.1%	38.3%
Low	64.5%	15.2%

EPS Forecast

EPS	2026	2027
High	-8.41	-3.89
Avg	-9.45	-3.77
Low	-10.31	-3.63

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.